Loss of MicroRNA-27b Contributes to Breast Cancer Stem Cell Generation by Activating ENPP1 The authors identified microRNA-27b (miR-27b) as a key regulator for the generation of a side-population in breast cancer cells that showed cancer stem cell properties, and also found that the anti-type II diabetes (T2D) drug metformin reduced this side-population via miR-27b-mediated repression of ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1), which is involved in T2D development. [Nat Commun] Full Article Tryptophan Derivatives Regulate the Transcription of Oct4 in Stem-Like Cancer Cells Reduction of endogenous ITE levels in cancer cells by tryptophan deprivation or hypoxia led to Oct4 elevation, which can be reverted by administration with synthetic ITE. Consequently, synthetic ITE induced the differentiation of stem-like cancer cells and reduced their tumorigenic potential in both subcutaneous and orthotopic xenograft tumor models. [Nat Commun] Full Article Tracking and Finding Slow-Proliferating/Quiescent Cancer Stem Cells with Fluorescent Nanodiamonds Using AS-B145-1R breast cancer cells as the model cell line for cancer stem cells, researchers found that the fluorescent nanodiamond labeling outperforms 5-ethynyl-2′-deoxyuridine and carboxyfluorescein diacetate succinimidyl ester in regards to its long-term tracking capability. [Small] Abstract p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion Investigators showed that p38γ activation promotes triple-negative breast cancer (TNBC) development and progression by stimulating cancer stem-like cell (CSC) expansion and may serve as a novel therapeutic target. p38γ silencing in TNBC cells reduced mammosphere formation and decreased expression levels of CSC drivers including Nanog, Oct3/4, and Sox2. [Stem Cells] Abstract FoxO1-Negative Cells Are Cancer Stem-Like Cells in Pancreatic Ductal Adenocarcinoma Researchers reported evidence of FoxO1-negative pancreatic ductal adenocarcinoma (PDAC) cells as cancer stem cells in PDAC. Both ALDH-high and CD133-high cell fractions isolated from PDAC of the patients expressed high levels of miR-21 and null FoxO1. [Sci Rep] Full Article Autocrine Human Growth Hormone Stimulates the Tumor Initiating Capacity and Metastasis of Estrogen Receptor-Negative Mammary Carcinoma Cells Scientists demonstrated that autocrine human growth hormone promoted cancer stem cell-like properties of estrogen receptor-negative mammary carcinoma cells in vitro. [Cancer Lett] Abstract Development of Novel Radio-Chemotherapy Approaches Targeting Prostate Tumor Progenitor Cells Using Nanohybrids Researchers describe the synthesis of biocompatible, catechin-loaded and gelatin-conjugated carbon nanotubes with anticancer properties and demonstrate their potential for the eradication of prostate cancer stem cells in combination with X-ray irradiation. [Int J Cancer] Abstract A Self-Enforcing CD44s/ZEB1 Feedback Loop Maintains EMT and Stemness Properties in Cancer Cells Scientists analyzed whether CD44 and ZEB1 regulate each other and showed that ZEB1 controls CD44s splicing by repression of ESRP1 in breast and pancreatic cancer. Activation of this novel CD44s-ZEB1 regulatory loop has functional impact on tumor cells, as evident by increased tumor-sphere initiation capacity, drug-resistance and tumor recurrence. [Int J Cancer] Abstract Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells Scientists focused on the ability of human adipose tissue derived mesenchymal stem cells to target brain tumor-initiating cells (BTICs) and their crosstalk in the microenvironment. BTICs were isolated from three different types of brain tumors. [PLoS One] Full Article Cancer Stem Cell Markers Are Associated with Distant Hematogenous Liver Metastases but Not with Peritoneal Carcinomatosis in Colorectal Cancer To analyze the expression of cancer stem cell markers immunohistochemistry for CD133, CD44 and β-catenin was applied to colorectal cancer (CRC) with exclusive peritoneal carcinomatosis, exclusive hepatic metastasis and CRC with combined spread. [Cancer Invest] Abstract An Aberrant Nuclear Localization of E-Cadherin Is a Potent Inhibitor of Wnt/β-Catenin-Elicited Promotion of the Cancer Stem Cell Phenotype Investigators conducted a series of in vitro and in vivo studies to show that the β-catenin/TCF4 interaction was abolished by E-cadherin and was correlated with its nuclear localization, and consequently decreased β-catenin/TCF4 transcriptional activity. [Oncogenesis] Full Article |